drugset / Trial / NCT02713113

Efficacy of Low Dose Sugammadex in Reversal of NMB in Laparoscopic Barbaric Surgery

NCT02713113

Phase 3 Completed 180 enrolled Assiut University
RandomizedParallel-groupDouble-blindHealth-services research

Summary

the investigators aimed to compare the efficacy and safety of sugammadex at doses of 1.5, 2, and 4 mg/ kg for the reversal of moderate rocuronium-induced neuromuscular blockade in laparoscopic bariatric surgery.

Timeline

Start
2015-03
Primary completion
2016-02
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Sugammadex Other / unclassified 1.5 mg/kg
Comparator Sugammadex Other / unclassified 2 mg/kg
Comparator Sugammadex Other / unclassified 4 mg/kg

Indications

No indication recorded.